Brian L. Strom (born December 8,1949) is the inaugural Chancellor of Rutgers Health and the Executive Vice President for Health Affairs at Rutgers University.[1] Strom was the Executive Vice Dean for Institutional Affairs,Founding Chair of the Department of Biostatistics and Epidemiology,Founding Director of the Center for Clinical Epidemiology and Biostatistics,and Founding Director of the Graduate Program in Epidemiology and Biostatistics,at the Perelman School of Medicine of the University of Pennsylvania. In addition to writing more than 650 papers and 15 books,he has been principal investigator for more than 275 grants. He was honored as one of the Best Doctors in America for each of his last eight years at Penn.
Strom is the Inaugural Chancellor of Rutgers Health (formerly Rutgers Biomedical and Health Sciences) and the Executive Vice President for Health Affairs at Rutgers University.[2] Rutgers Health is composed of eight schools and seven major centers/institutes,and includes academic,patient care,and research facilities. These are most of the units of the former University of Medicine and Dentistry of New Jersey (UMDNJ),now dissolved,several Rutgers University units with health-related missions,and two research units historically co-managed by Rutgers and UMDNJ. The integration of these entities is designed to create a single organization that will lead to new models for clinical care and community service,educate the next generation of health care providers utilizing health care team approaches,and conduct research.
Strom has also done much work in clinical research training. At Penn,Strom developed graduate training programs in epidemiology and biostatistics. More than 625 clinicians trained through the largest of these programs,which leads to a Master of Science in Clinical Epidemiology. All but approximately 65 have appointments in academic or other research institutions. Strom was PI or Co-PI of 11 different NIH-funded training grants,each of which supported clinical epidemiology trainees in different specialties and subspecialties,and was the primary mentor for more than 40 clinical research trainees and numerous junior faculty members. Internationally,Dr. Strom was a key contributor to the conceptualization and planning that led to the development of the International Clinical Epidemiology Network (INCLEN),created in 1979 with support provided by the Rockefeller Foundation to provide clinical research training to clinicians from selected developing country sites. Penn was an INCLEN founding member and one of five training centers. INCLEN Phase I,from 1979 through 1995,resulted in the establishment of 26 clinical epidemiology units in Latin America,India,Africa,and Southeast Asia.
Research
Strom's major research interest is in the field of pharmacoepidemiology,i.e.,the application of epidemiologic methods to the study of drug use and effects. He is recognized as a founder of this field and for his pioneer work in using large automated databases for research. He is editor of the field's major text (now in its fifth edition) and Editor-in-Chief for Pharmacoepidemiology and Drug Safety,the official journal of the International Society for Pharmacoepidemiology.[3] As one of many specific contributions,his research was pivotal in prompting the American Heart Association and American Dental Association to reverse 50 years of guidelines,and recommend against use of antibiotics to prevent infective endocarditis,instead of recommending for this widespread practice. In addition to writing more than 650 papers and 15 books,he has been principal investigator for more than 275 grants,including over $115 million in direct costs alone. Strom has been invited to give more than 450 talks outside his local area,including presentations as the keynote speaker for numerous international meetings. He has been a consultant to NIH,FDA,CDC,USP,AAMC,JCAHO,foreign governments,most major pharmaceutical manufacturers,and many law firms.
2008 John Phillips Memorial Award for Outstanding Work in Clinical Medicine,American College of Physicians
2008 Elected Fellow,American College of Preventive Medicine
2008 Harry Guess Memorial Lecture,The University of North Carolina School of Public Health Chapter of the International Society for Pharmacoepidemiology,Department of Epidemiology
2008 Winner,ISPE - Pharmacoepidemiology and Drug Safety Best Article Award
2008 Commended Paper,ISPE - Pharmacoepidemiology and Drug Safety Best Article Award
2009-2010 Recognized by Best Doctors in America
2009 UPHS Quality and Patient Safety Honorable Mention Award,University of Pennsylvania Health System
2011-2012 Recognized by Best Doctors in America
2011 National Associate of the National Academies
2012 Contraception Outstanding Article Award for 2012
2013 Association for Clinical and Translational Science/American Federation for Medical Research National Award for Career Achievement and Contribution to Clinical and Translational Science for translation from clinical use into public benefit and policy
2013 Dennis J. Sullivan Award,New Jersey Public Health Association
Joellenbeck LM,Zwanziger LL,Durch JS,Strom BL (eds). Committee to Assess the Safety and Efficacy of the Anthrax Vaccine,Medical Follow-up Agency. The Anthrax Vaccine:Is It Safe? Does It Work? Washington,DC:National Academy Press,2002.
Committee on Smallpox Vaccination Program Implementation,Board on Health Promotion and Disease Prevention;Baciu A,Anason AP,Stratton K,Strom BL (eds). The Smallpox Vaccination Program:Public Health in an Age of Terrorism. Washington,DC:The National Academies Press,2005.
Strom BL,Kimmel SE (eds). Textbook of Pharmacoepidemiology. Sussex:John Wiley,2006.
Strom BL,Yaktine AL,Oria M. Sodium Intake in Populations:Assessment of Evidence. Washington,DC:The National Academies Press,2013.
Strom BL,Kimmel SE,Hennessy S (eds). Textbook of Pharmacoepidemiology (Second Edition). Chichester:JohnWiley,2013.
Committee on a National Strategy for the Elimination of Hepatitis B and C,Board on Population Health and Public Health Practice,Health and Medicine Division;Buckley GJ,Strom BL (eds). Eliminating the Public Health Problem of Hepatitis B and C in the United States:Phase One Report. Washington,DC:The National Academies Press,2016.
Committee on a National Strategy for the Elimination of Hepatitis B and C,Board on Population Health and Public Health Practice,Health and Medicine Division;Buckley GJ,Strom BL (eds). Eliminating the Public Health Problem of Hepatitis B and C in the United States:Phase Two Report. Washington,DC:The National Academies Press,2017.
Strom BL,Kimmel SE,Hennessy SH (eds). Pharmacoepidemiology (Sixth Edition). John Wiley and Sons,2019.
An Approach to Evaluate the Effects on Concomitant Prescribing of Opioids and Benzodiazepines on Veteran Deaths and Suicides. Strom BL,Bohnert AS,Gerhard T,Hernan M,King VL,Lewis R,Merlin J,Paddock S (eds). The National Academies Press,2019.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
